Marea Therapeutics is a biotechnology research company headquartered in South San Francisco, California. The company focuses on developing novel therapeutics within the biopharma sector.
Subscribe to see Marea Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Marea Therapeutics, Inc. is a biotech company headquartered in United States. Its most recent funding round raised $190M in June 2024. Xcout recorded 14 job postings from Marea Therapeutics, Inc. in the last 90 days.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $190M | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 14 job postings from Marea Therapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Marea Therapeutics, Inc.'s hiring signals →
A few of Marea Therapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Circle Pharma, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, harnessing macrocycles for drug development.
Switch Therapeutics Inc. is a biotechnology company headquartered in South San Francisco, California. Founded in 2020, the company develops RNAi therapies based on its proprietary technology.
Addition Therapeutics is a biotechnology research company based in South San Francisco, California. The firm is on a mission to fulfill the promise of genomic medicine for chronic and rare diseases, having emerged from stealth with significant funding.
Dualitas Therapeutics is a privately held biotechnology research company headquartered in South San Francisco, California, that utilizes its DualScreen Bispecific Discovery Engine for proximity engagers.
Rezo Therapeutics, Inc. is a biotechnology company headquartered in South San Francisco, California, that integrates proteomics, genetics, and structural biology for drug discovery and development.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.